Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Optinose Inc (NQ: OPTN )

1.080 +0.070 (+6.93%)
Streaming Delayed Price Updated: 11:21 AM EDT, May 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Optinose Inc

< Previous 1 2 3 4 Next >
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Bristol-Myers Squibb Layoffs 2024: What to Know About the Latest BMY Job Cuts
Bristol-Myers Squibb layoffs will see the company reduce its headcount by 6% as part of an effort to reduce expenses in 2024. 
Via InvestorPlace
Topics Workforce
Exposures Layoff
Why Are Stocks Down Today?
Stocks are down today and investors wondering why have come to the right place as we have all the news on the market drop on Thursday. 
Via InvestorPlace
OptiNose's Earnings: A Preview
Via Benzinga
Why Is OptiNose (OPTN) Stock Up 12% Today?
OptiNose stock is taking off on Thursday alongside an update on XHANCE that brings heavy trading to OPTN shares this morning. 
Via InvestorPlace
Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million
Conference Call and Webcast to be held April 25, 2024, at 10:00 a.m. Eastern Time 
From Optinose, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Optinose to Present at the Needham Virtual Healthcare Conference
From Optinose, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps
From Optinose, Inc.
Via GlobeNewswire
OPTN Stock Earnings: OptiNose Meets EPS, Beats Revenue for Q4 2023
OPTN stock results show that OptiNose met analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Optinose Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights
From Optinose, Inc.
Via GlobeNewswire
Earnings Scheduled For March 7, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million. 
Via Benzinga
Optinose Announces Reporting Date for Fourth Quarter 2023 Financial Results
Conference Call and Webcast to be held March 7, 2024, at 8:00 a.m. Eastern Time 
From Optinose, Inc.
Via GlobeNewswire
Optinose Announces the Publication of ReOpen Phase 3 Clinical Trial Program Evaluating XHANCE in the Journal of Allergy and Clinical Immunology: In Practice
From Optinose, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Gold Moves Higher; Campbell Soup Earnings Top Expectations
U.S. stocks traded mixed toward the end of trading on Wednesday. The Dow traded up 0.05% to 36,143.40 while the NASDAQ fell 0.06% to 14,221.51. The S&P 500 also fell, dropping, 0.05% to 4,564.73. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second-quarter results. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Crude Oil Down 4%; Pharvaris Shares Spike Higher
U.S. stocks traded mostly flat midway through trading, with the S&P 500 turning lower on Wednesday. The Dow traded up 0.01% to 36,126.75 while the NASDAQ rose 0.03% to 14,233.77. The S&P 500 also fell,... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
US Stocks Higher; Private Payrolls Rise By 103,000 In November
U.S. stocks traded higher this morning, following the release of economic reports on Wednesday. Following the market opening Wednesday, the Dow traded up 0.21% to 36,200.86 while the NASDAQ rose 0.28%... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why ENT-Focused OptiNose Shares Are Diving Today
OptiNose, Inc. (NASDAQ: OPTN) shares are trading lower after the company announced a three-month extension of the FDA review period for the supplemental new drug application for 
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Optinose Announces 3-Month Extension of FDA Review Period for the Supplemental New Drug Application for XHANCE
From Optinose, Inc.
Via GlobeNewswire
Optinose to Present at the 35th Annual Piper Sandler Healthcare Conference
From Optinose, Inc.
Via GlobeNewswire
Optinose Reports Third Quarter 2023 Financial Results and Operational Updates
From Optinose, Inc.
Via GlobeNewswire
Optinose Announces Reporting Date for Third Quarter 2023 Financial Results
Conference Call and Webcast to be held November 9, 2023, at 8:00 a.m. Eastern Time 
From Optinose, Inc.
Via GlobeNewswire
Optinose to Present at the 2023 Cantor Global Healthcare Conference
From Optinose, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 21, 2023
Via Benzinga
Optinose Reports Second Quarter 2023 Financial Results and Operational Updates
From Optinose, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.